Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-03

AUTHORS

F. Porchet, R. Chioléro, N. de Tribolet

ABSTRACT

To determine the incidence of induced systemic hypotension in patients after aneurysmal subarachnoid haemorrhage (SAH) and nimodipine treatment 87 consecutive cases were reviewed.The patients were managed according to the same Nimodipine treatment protocol. After confirmation of SAH the nimodipine treatment was started as a continuous intravenous perfusion at a dosage of 0.5 mg/h and gradually increased every 6 hours if haemodynamically tolerated until the maintenance dose of 2 mg/h was reached. Median systemic pressure was continuously measured and tolerated until a lowest limit of 75 mmHg. In 31 patients (36%) hypotension with values below 75 mmHg during at least 30 minutes was noted and needed Nimodipine reduction. Intravenous Nimodipine administration was responsible for hypotension in 26 cases as compared to 5 cases due to oral administration. 38% of all patients required support by vaso-active agents (Dopamine or Noradrenaline).There was no statistically significant difference of incidence of delayed ischaemic deterioration comparing the Nimodipine-reduction group with the normal dose group.This study demonstrates that a considerable risk exists of Nimodipine induced hypotension in intravenous administration despite gradually increasing the doses. Correction of hypotension through further induced hypervolaemia accompanied by vasoactive agents can lead to critical haemodynamic situations. We therefore recommend oral Nimodipine administration. More... »

PAGES

62-69

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf02188783

DOI

http://dx.doi.org/10.1007/bf02188783

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016957954

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8748871


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aneurysm, Ruptured", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Blockers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypotension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intracranial Aneurysm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurologic Examination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nimodipine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Subarachnoid Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, University Hospital, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.8515.9", 
          "name": [
            "Department of Neurosurgery, University Hospital, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porchet", 
        "givenName": "F.", 
        "id": "sg:person.01104633456.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104633456.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anaesthesiology, University Hospital, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.8515.9", 
          "name": [
            "Department of Anaesthesiology, University Hospital, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiol\u00e9ro", 
        "givenName": "R.", 
        "id": "sg:person.01121362247.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121362247.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurosurgery, University Hospital, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.8515.9", 
          "name": [
            "Department of Neurosurgery, University Hospital, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Tribolet", 
        "givenName": "N.", 
        "id": "sg:person.01134324113.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134324113.90"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01406611", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008117768", 
          "https://doi.org/10.1007/bf01406611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01402190", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037483923", 
          "https://doi.org/10.1007/bf01402190"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01402513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048637769", 
          "https://doi.org/10.1007/bf01402513"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01420184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011890773", 
          "https://doi.org/10.1007/bf01420184"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01403488", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030197223", 
          "https://doi.org/10.1007/bf01403488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01560561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046762807", 
          "https://doi.org/10.1007/bf01560561"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-03", 
    "datePublishedReg": "1995-03-01", 
    "description": "To determine the incidence of induced systemic hypotension in patients after aneurysmal subarachnoid haemorrhage (SAH) and nimodipine treatment 87 consecutive cases were reviewed.The patients were managed according to the same Nimodipine treatment protocol. After confirmation of SAH the nimodipine treatment was started as a continuous intravenous perfusion at a dosage of 0.5 mg/h and gradually increased every 6 hours if haemodynamically tolerated until the maintenance dose of 2 mg/h was reached. Median systemic pressure was continuously measured and tolerated until a lowest limit of 75 mmHg. In 31 patients (36%) hypotension with values below 75 mmHg during at least 30 minutes was noted and needed Nimodipine reduction. Intravenous Nimodipine administration was responsible for hypotension in 26 cases as compared to 5 cases due to oral administration. 38% of all patients required support by vaso-active agents (Dopamine or Noradrenaline).There was no statistically significant difference of incidence of delayed ischaemic deterioration comparing the Nimodipine-reduction group with the normal dose group.This study demonstrates that a considerable risk exists of Nimodipine induced hypotension in intravenous administration despite gradually increasing the doses. Correction of hypotension through further induced hypervolaemia accompanied by vasoactive agents can lead to critical haemodynamic situations. We therefore recommend oral Nimodipine administration.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf02188783", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1412990", 
        "issn": [
          "0001-6268", 
          "0942-0940"
        ], 
        "name": "Acta Neurochirurgica", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1-2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "137"
      }
    ], 
    "keywords": [
      "aneurysmal subarachnoid hemorrhage", 
      "subarachnoid hemorrhage", 
      "nimodipine administration", 
      "continuous intravenous perfusion", 
      "vaso-active agents", 
      "correction of hypotension", 
      "normal-dose group", 
      "patient's hypotension", 
      "systemic hypotension", 
      "nimodipine treatment", 
      "maintenance dose", 
      "intravenous perfusion", 
      "ischemic deterioration", 
      "hypotensive effect", 
      "dose group", 
      "vasoactive agents", 
      "consecutive cases", 
      "haemodynamic situation", 
      "oral administration", 
      "treatment protocol", 
      "intravenous administration", 
      "hypotension", 
      "systemic pressure", 
      "patients", 
      "administration", 
      "hemorrhage", 
      "significant differences", 
      "mmHg", 
      "nimodipine", 
      "incidence", 
      "treatment", 
      "risk exist", 
      "hypervolaemia", 
      "group", 
      "perfusion", 
      "agents", 
      "dose", 
      "doses", 
      "cases", 
      "dosage", 
      "minutes", 
      "hours", 
      "confirmation", 
      "deterioration", 
      "differences", 
      "study", 
      "protocol", 
      "lower limit", 
      "reduction", 
      "effect", 
      "pressure", 
      "support", 
      "correction", 
      "exists", 
      "values", 
      "situation", 
      "limit"
    ], 
    "name": "Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage", 
    "pagination": "62-69", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016957954"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf02188783"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8748871"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf02188783", 
      "https://app.dimensions.ai/details/publication/pub.1016957954"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_275.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf02188783"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02188783'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02188783'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02188783'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02188783'


 

This table displays all metadata directly associated to this object as RDF triples.

238 TRIPLES      21 PREDICATES      109 URIs      95 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf02188783 schema:about N1acc3f385d0f433fbe178b5cb21da302
2 N209db4c5538843eaa9e2ee23add23d57
3 N20c598ae8a9248799db5074be55900a3
4 N3af23aa17dc54c469875c304923941c9
5 N43728dae9bfc45a885685a0e3a32b25b
6 N63d2d11389d946ff8e822c951e6e0e2a
7 N699aaa8e8b0a45beb253ed721194f07b
8 N75ac376fc5bc4a19bbc66e5a391f2368
9 N7894d5124a5a46a79fad277fa70d4fb9
10 N871d78acfda64b0c972db3995d543464
11 N8958d760d4764fe59e8a889919fb3acf
12 N9a20572620094c5391893f42f1194957
13 N9bb2f410086243c199b3b7fc3bacde34
14 Na1566d91de2e4ef4858b9ad7a87e0eb6
15 Na9f26a959e024f5e8f9df90bf69cafb2
16 Nb2d2eb07d2834b80807b070c32f89d55
17 Nbc57d9d4c71d4b6191f8cfad4d8727e1
18 Nbd19cf14a1ca46779d7695cb59324060
19 Nbf43aaa94ec94d889230657cafbfaa52
20 Nfabb51cbc01147e09ddd5a5cbe29c610
21 anzsrc-for:11
22 anzsrc-for:1102
23 schema:author N09b3ba8a832b4d73bdb9ebfdfb329055
24 schema:citation sg:pub.10.1007/bf01402190
25 sg:pub.10.1007/bf01402513
26 sg:pub.10.1007/bf01403488
27 sg:pub.10.1007/bf01406611
28 sg:pub.10.1007/bf01420184
29 sg:pub.10.1007/bf01560561
30 schema:datePublished 1995-03
31 schema:datePublishedReg 1995-03-01
32 schema:description To determine the incidence of induced systemic hypotension in patients after aneurysmal subarachnoid haemorrhage (SAH) and nimodipine treatment 87 consecutive cases were reviewed.The patients were managed according to the same Nimodipine treatment protocol. After confirmation of SAH the nimodipine treatment was started as a continuous intravenous perfusion at a dosage of 0.5 mg/h and gradually increased every 6 hours if haemodynamically tolerated until the maintenance dose of 2 mg/h was reached. Median systemic pressure was continuously measured and tolerated until a lowest limit of 75 mmHg. In 31 patients (36%) hypotension with values below 75 mmHg during at least 30 minutes was noted and needed Nimodipine reduction. Intravenous Nimodipine administration was responsible for hypotension in 26 cases as compared to 5 cases due to oral administration. 38% of all patients required support by vaso-active agents (Dopamine or Noradrenaline).There was no statistically significant difference of incidence of delayed ischaemic deterioration comparing the Nimodipine-reduction group with the normal dose group.This study demonstrates that a considerable risk exists of Nimodipine induced hypotension in intravenous administration despite gradually increasing the doses. Correction of hypotension through further induced hypervolaemia accompanied by vasoactive agents can lead to critical haemodynamic situations. We therefore recommend oral Nimodipine administration.
33 schema:genre article
34 schema:isAccessibleForFree false
35 schema:isPartOf N548944a713b14ee19c34532dafb391e8
36 N87cce817ce2547aca9b8027a68eca852
37 sg:journal.1412990
38 schema:keywords administration
39 agents
40 aneurysmal subarachnoid hemorrhage
41 cases
42 confirmation
43 consecutive cases
44 continuous intravenous perfusion
45 correction
46 correction of hypotension
47 deterioration
48 differences
49 dosage
50 dose
51 dose group
52 doses
53 effect
54 exists
55 group
56 haemodynamic situation
57 hemorrhage
58 hours
59 hypervolaemia
60 hypotension
61 hypotensive effect
62 incidence
63 intravenous administration
64 intravenous perfusion
65 ischemic deterioration
66 limit
67 lower limit
68 maintenance dose
69 minutes
70 mmHg
71 nimodipine
72 nimodipine administration
73 nimodipine treatment
74 normal-dose group
75 oral administration
76 patient's hypotension
77 patients
78 perfusion
79 pressure
80 protocol
81 reduction
82 risk exist
83 significant differences
84 situation
85 study
86 subarachnoid hemorrhage
87 support
88 systemic hypotension
89 systemic pressure
90 treatment
91 treatment protocol
92 values
93 vaso-active agents
94 vasoactive agents
95 schema:name Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage
96 schema:pagination 62-69
97 schema:productId N97a1e38f01b4497e8432501a6b7ac014
98 Nd2d9f24db8014fd29cb79fcb60ba4aa6
99 Ne95506ac1a0d4414a4a71909a9aa0a2f
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016957954
101 https://doi.org/10.1007/bf02188783
102 schema:sdDatePublished 2022-09-02T15:47
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N13bb7fa949654dd6a3e4efe71cb1972f
105 schema:url https://doi.org/10.1007/bf02188783
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N09b3ba8a832b4d73bdb9ebfdfb329055 rdf:first sg:person.01104633456.13
110 rdf:rest N3c5a918b6ca04208a8e9f049a9114f5c
111 N13bb7fa949654dd6a3e4efe71cb1972f schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N1acc3f385d0f433fbe178b5cb21da302 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hemodynamics
115 rdf:type schema:DefinedTerm
116 N209db4c5538843eaa9e2ee23add23d57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Infusions, Intravenous
118 rdf:type schema:DefinedTerm
119 N20c598ae8a9248799db5074be55900a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N3af23aa17dc54c469875c304923941c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Subarachnoid Hemorrhage
124 rdf:type schema:DefinedTerm
125 N3c5a918b6ca04208a8e9f049a9114f5c rdf:first sg:person.01121362247.08
126 rdf:rest N554fb72e378d47e5be2272b3bbcf1c7a
127 N43728dae9bfc45a885685a0e3a32b25b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 N548944a713b14ee19c34532dafb391e8 schema:issueNumber 1-2
131 rdf:type schema:PublicationIssue
132 N554fb72e378d47e5be2272b3bbcf1c7a rdf:first sg:person.01134324113.90
133 rdf:rest rdf:nil
134 N63d2d11389d946ff8e822c951e6e0e2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Nimodipine
136 rdf:type schema:DefinedTerm
137 N699aaa8e8b0a45beb253ed721194f07b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Intracranial Aneurysm
139 rdf:type schema:DefinedTerm
140 N75ac376fc5bc4a19bbc66e5a391f2368 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Hypotension
142 rdf:type schema:DefinedTerm
143 N7894d5124a5a46a79fad277fa70d4fb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Adult
145 rdf:type schema:DefinedTerm
146 N871d78acfda64b0c972db3995d543464 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Administration, Oral
148 rdf:type schema:DefinedTerm
149 N87cce817ce2547aca9b8027a68eca852 schema:volumeNumber 137
150 rdf:type schema:PublicationVolume
151 N8958d760d4764fe59e8a889919fb3acf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Blood Pressure
153 rdf:type schema:DefinedTerm
154 N97a1e38f01b4497e8432501a6b7ac014 schema:name pubmed_id
155 schema:value 8748871
156 rdf:type schema:PropertyValue
157 N9a20572620094c5391893f42f1194957 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Middle Aged
159 rdf:type schema:DefinedTerm
160 N9bb2f410086243c199b3b7fc3bacde34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Aged
162 rdf:type schema:DefinedTerm
163 Na1566d91de2e4ef4858b9ad7a87e0eb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Male
165 rdf:type schema:DefinedTerm
166 Na9f26a959e024f5e8f9df90bf69cafb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Brain
168 rdf:type schema:DefinedTerm
169 Nb2d2eb07d2834b80807b070c32f89d55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Calcium Channel Blockers
171 rdf:type schema:DefinedTerm
172 Nbc57d9d4c71d4b6191f8cfad4d8727e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Neurologic Examination
174 rdf:type schema:DefinedTerm
175 Nbd19cf14a1ca46779d7695cb59324060 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Aneurysm, Ruptured
177 rdf:type schema:DefinedTerm
178 Nbf43aaa94ec94d889230657cafbfaa52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Female
180 rdf:type schema:DefinedTerm
181 Nd2d9f24db8014fd29cb79fcb60ba4aa6 schema:name dimensions_id
182 schema:value pub.1016957954
183 rdf:type schema:PropertyValue
184 Ne95506ac1a0d4414a4a71909a9aa0a2f schema:name doi
185 schema:value 10.1007/bf02188783
186 rdf:type schema:PropertyValue
187 Nfabb51cbc01147e09ddd5a5cbe29c610 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Dose-Response Relationship, Drug
189 rdf:type schema:DefinedTerm
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
194 schema:name Cardiorespiratory Medicine and Haematology
195 rdf:type schema:DefinedTerm
196 sg:journal.1412990 schema:issn 0001-6268
197 0942-0940
198 schema:name Acta Neurochirurgica
199 schema:publisher Springer Nature
200 rdf:type schema:Periodical
201 sg:person.01104633456.13 schema:affiliation grid-institutes:grid.8515.9
202 schema:familyName Porchet
203 schema:givenName F.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104633456.13
205 rdf:type schema:Person
206 sg:person.01121362247.08 schema:affiliation grid-institutes:grid.8515.9
207 schema:familyName Chioléro
208 schema:givenName R.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121362247.08
210 rdf:type schema:Person
211 sg:person.01134324113.90 schema:affiliation grid-institutes:grid.8515.9
212 schema:familyName de Tribolet
213 schema:givenName N.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134324113.90
215 rdf:type schema:Person
216 sg:pub.10.1007/bf01402190 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037483923
217 https://doi.org/10.1007/bf01402190
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/bf01402513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048637769
220 https://doi.org/10.1007/bf01402513
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/bf01403488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030197223
223 https://doi.org/10.1007/bf01403488
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/bf01406611 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008117768
226 https://doi.org/10.1007/bf01406611
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/bf01420184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011890773
229 https://doi.org/10.1007/bf01420184
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/bf01560561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046762807
232 https://doi.org/10.1007/bf01560561
233 rdf:type schema:CreativeWork
234 grid-institutes:grid.8515.9 schema:alternateName Department of Anaesthesiology, University Hospital, Lausanne, Switzerland
235 Department of Neurosurgery, University Hospital, Lausanne, Switzerland
236 schema:name Department of Anaesthesiology, University Hospital, Lausanne, Switzerland
237 Department of Neurosurgery, University Hospital, Lausanne, Switzerland
238 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...